We only need ONE DRUG company to realize the gravity of this Platform Drug..and the gloves are off for those who try to negate its potential...there will always be potential for treatments...to insure future revenue streams don't stop...that's the job of lobbyists currying favor...and CEO's trying to leave their mark on history...hard to stuff ...back in the box.